IDEAYA Biosciences (IDYA) Other Operating Expenses (2022 - 2025)

IDEAYA Biosciences (IDYA) has 4 years of Other Operating Expenses data on file, last reported at $49.6 million in Q3 2025.

• For the quarter ending Q3 2025, Other Operating Expenses rose 41.35% year-over-year to $49.6 million; the trailing twelve-month figure through Mar 2026 stood at $49.6 million (down 69.68% YoY), and the FY2024 full-year result was $211.2 million, up 151.89% from the prior year.
• Other Operating Expenses eased to $49.6 million in Q3 2025, from $128.4 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $128.4 million in Q4 2024 to a low of $35.1 million in Q3 2024.
• A 4-year average of $69.8 million and a median of $52.3 million in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses surged 60.28% in 2023 and soared 41.35% in 2025, its largest moves.
• Tracing IDYA's Other Operating Expenses over 4 years: stood at $52.3 million in 2022, then jumped by 60.28% to $83.9 million in 2023, then surged by 53.08% to $128.4 million in 2024, then plunged by 61.4% to $49.6 million in 2025.
• Business Quant data shows IDYA's Other Operating Expenses at $49.6 million in Q3 2025, $128.4 million in Q4 2024, and $35.1 million in Q3 2024.